Following the successful integration of eyeshadow try-on earlier this spring, Sephora, the leader in global prestige beauty retail, continues to drive mobile engagement with the launch of even more augmented reality-based features to Sephora Virtual Artist on its award-winning iOS and Android apps. New today are Cheek Try On, which allows users to virtually try on over 1,000 shades of cheek color, an expanded library of Looks, and a Color Match for Virtual Try On feature, which uses Artificial Intelligence to detect and accurately estimate the shade in any photo and match it with a lip, eyeshadow or cheek products available at Sephora. Available in the Sephora app, these new features for Sephora Virtual Artist are the latest in a series of digital enhancements powered by the Sephora Innovation Lab to customize the retailer’s expanding beauty experiences.
To view the multimedia release go to:
https://www.multivu.com/players/English/7926154-sephora-virtual-artist-cheek-try-on-color-match/
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
Parking crashes usually don’t result in serious injuries, but repair costs can quickly mount, along with the hassle of going without the family vehicle while waiting for the body shop to finish work. The Insurance Institute for Highway Safety has launched a rear crash prevention ratings program to help consumers identify models with the technology that can prevent or mitigate low-speed backing crashes. Two systems earn the highest rating of superior, and four earn the second-highest rating of advanced.
Rear crash prevention encompasses several technologies. Parking sensors issue warning beeps and/or seat vibrations when the equipped vehicle gets too close to another vehicle or object directly behind it, or, in some cases, in front of it. Rear cross-traffic alert warns drivers of approaching vehicles that might cross their path as they back up. Rear automatic emergency braking systems detect objects behind a reversing vehicle and may automatically brake if the driver doesn’t heed alerts to stop.
IIHS engineers evaluated rear autobrake systems on six popular 2017 model vehicles — the BMW 5 series sedan, Cadillac XT5 SUV, Infiniti QX60 SUV, Jeep Cherokee SUV, Subaru Outback wagon and Toyota Prius hatchback.
Under the three-tier rating scheme, models with optional or standard rear crash prevention systems are rated superior, advanced or basic. Ratings are determined by whether the vehicles have available rear autobrake and, if so, how it performs in a series of car-to-car and car-to-pole tests with different approach angles. The availability of parking sensors and rear cross-traffic alert also is factored in.
The Outback and XT5 earn a superior rating when equipped with optional rear autobrake, parking sensors and rear cross-traffic alert. The Cherokee, 5 series, QX60 and Prius earn an advanced rating with this optional gear.